<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 13 Aug 2026 18:06:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;R$448 Million Returned to Shareholders
&lt;br&gt;&lt;/br&gt;&lt;/b&gt;&lt;b&gt;106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34)&lt;/b&gt; (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”).

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Second Quarter 2026 Highlights&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistsquare&quot;&gt;
&lt;li&gt;
2Q26 Revenue increased 5.7% YoY to R$972.1 million. Revenue excluding acquisitions increased 5.4%, reaching R$969.3</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Limited+Announces+Second-Quarter+and+First-Half+2026+Financial+Results/26923007.html</guid>
   <pubDate>Thu, 13 Aug 2026 18:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204866</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184011</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee</title>
   <link>http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company&lt;/b&gt;”&lt;b&gt;)&lt;/b&gt;, the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

&lt;/p&gt;&lt;p&gt;
Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financial expert, succeeds João Paulo Seibel de Faria as the Chair Member of the Audit, Risks and Ethics Committee and will continue</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Afya+Announces+Appointment+of+Marcelo+Ken+Suhara+as+the+Chair+Member+of+the+Audit%2C+Risks+and+Ethics+Committee/26836798.html</guid>
   <pubDate>Wed, 29 Jul 2026 18:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19004573</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00247323</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Releases 2025 Integrated Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”),&lt;/b&gt; the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2025 Integrated Report.

&lt;/p&gt;&lt;p&gt;
The document presents Afya's trajectory throughout 2025, representing the Company's best operational performance since IPO, and marks the full adoption of the Integrated Reporting framework, providing an integrated view of the Company's performance, strategy, and value creation. This edition also includes a new chapter on technology and Artificial Intelligence, outlining how Afya is integrating AI into its medical education and healthcare solutions through dedicated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</guid>
   <pubDate>Wed, 10 Jun 2026 19:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32536489</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998283</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Releases 2025 Integrated Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”),&lt;/b&gt; the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2025 Integrated Report.

&lt;/p&gt;&lt;p&gt;
The document presents Afya's trajectory throughout 2025, representing the Company's best operational performance since IPO, and marks the full adoption of the Integrated Reporting framework, providing an integrated view of the Company's performance, strategy, and value creation. This edition also includes a new chapter on technology and Artificial Intelligence, outlining how Afya is integrating AI into its medical education and healthcare solutions through dedicated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</guid>
   <pubDate>Wed, 10 Jun 2026 19:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32536489</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998283</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Releases 2025 Integrated Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”),&lt;/b&gt; the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2025 Integrated Report.

&lt;/p&gt;&lt;p&gt;
The document presents Afya's trajectory throughout 2025, representing the Company's best operational performance since IPO, and marks the full adoption of the Integrated Reporting framework, providing an integrated view of the Company's performance, strategy, and value creation. This edition also includes a new chapter on technology and Artificial Intelligence, outlining how Afya is integrating AI into its medical education and healthcare solutions through dedicated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</guid>
   <pubDate>Wed, 10 Jun 2026 19:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32536489</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998283</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Releases 2025 Integrated Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”),&lt;/b&gt; the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2025 Integrated Report.

&lt;/p&gt;&lt;p&gt;
The document presents Afya's trajectory throughout 2025, representing the Company's best operational performance since IPO, and marks the full adoption of the Integrated Reporting framework, providing an integrated view of the Company's performance, strategy, and value creation. This edition also includes a new chapter on technology and Artificial Intelligence, outlining how Afya is integrating AI into its medical education and healthcare solutions through dedicated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</guid>
   <pubDate>Wed, 10 Jun 2026 19:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32536489</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998283</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
  <item>
   <title>Afya Limited Releases 2025 Integrated Report</title>
   <link>http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</link>
   <description>
&lt;p&gt;    BELO HORIZONTE, Brazil--(BUSINESS WIRE)--
&lt;b&gt;Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”),&lt;/b&gt; the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2025 Integrated Report.

&lt;/p&gt;&lt;p&gt;
The document presents Afya's trajectory throughout 2025, representing the Company's best operational performance since IPO, and marks the full adoption of the Integrated Reporting framework, providing an integrated view of the Company's performance, strategy, and value creation. This edition also includes a new chapter on technology and Artificial Intelligence, outlining how Afya is integrating AI into its medical education and healthcare solutions through dedicated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Afya+Limited+Releases+2025+Integrated+Report/26631201.html</guid>
   <pubDate>Wed, 10 Jun 2026 19:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.32536489</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A2FY34</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFYA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998283</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41509575</category>
   	  </item>
 </channel>
</rss>
